Advance Directives and End-of-life Decision Making in Intensive Care Medicine in Germany
NCT ID: NCT01294189
Last Updated: 2011-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
224 participants
OBSERVATIONAL
2008-08-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Quality Indicators on Analgesia, Sedation and Delirium in Intensive Care Patients and Their Impact on Outcome Indicators and Economic Indicators
NCT05384613
Post-ICU Consultation : a Time to Discuss Advance Directives (CoPRADA)
NCT05817500
(DIS)AGreement of Relatives Regarding Ethical End-of-life Decisions in ICU.
NCT05768906
Identification of Outcome Relevant Indicators in Routine Data
NCT04670744
Design and Validation of a German Language Questionnaire for Measuring Alarm Fatigue in Intensive Care Units
NCT04994600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this observational study is to describe the decision making process as well as the practices of end of life care in an ICU of a German university hospital during a period when changes of German legislation occurred.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU-patients that died on the ICU
ICU-patients (post-operative and non operative patients) will be enrolled in the study. All patients are followed until their death on the ICU.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients discharged death from the ICU
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charite University, Berlin, Germany
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan-Peter Braun, MD
Role: STUDY_DIRECTOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology and Operative Intensive Care Medicine Campus Charité Mitte
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Graw JA, Spies CD, Wernecke KD, Braun JP. Managing end-of-life decision making in intensive care medicine--a perspective from Charite Hospital, Germany. PLoS One. 2012;7(10):e46446. doi: 10.1371/journal.pone.0046446. Epub 2012 Oct 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EOLD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.